The β-lactamases of Moraxella (Branhamella) catarrhalis isolated from Danish children

APMIS

Volumn 104, Issue 7-8, 1996, Pages 557-562

  Ejlertsen, T ^a   Skov, R ^b  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

BRO 1; BRO 2; Isoelectric focusing; lactamases

Indexed keywords

AMOXICILLIN; AMPICILLIN; BETA LACTAMASE; CEFUROXIME; CLAVULANIC ACID; NITROCEFIN; PENICILLIN V;

ARTICLE; CONTROLLED STUDY; DENMARK; DRUG RESISTANCE; HUMAN; ISOELECTRIC FOCUSING; LOWER RESPIRATORY TRACT INFECTION; MORAXELLA CATARRHALIS; PRESCHOOL CHILD; PRIORITY JOURNAL;

EID: 0029854534     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1996.tb04911.x     Document Type: Article

References (19)

1. Bush, K.: Classification of β-lactamases: groups 2c, 2d, 2e, 3 and 4. Antimicrob. Agents Chemother. 33: 271-276, 1989.
2. Christensen, J. J., Keiding, J. & Bruun, B.: Antimicrobial susceptibility and β-lactamase characterization of B. catarrhalis isolates from 1983/ 1984 and 1988. APMIS 98: 1039-1044, 1990.
3. Christensen, J. J., Keiding, J., Schumacher, H. & Bruun, B.: Recognition of a new Branhamella catarrhalis β-lactamase. BRO-3. J. Antimicrob. Chemother. 28: 774-775, 1992.
4. Doern, G. V. & Tubert, T.: Disk diffusion susceptibility testing of Branhamella catarrhalis with ampicillin and seven other antimicrobial agents. Antimicrob. Agents Chemother. 31: 1519-1523, 1987.
5. Eliasson, J. & Kamme, C.: Characterization of the plasmid-mediated β-lactamase in Branhamella catarrhalis, with special reference to substrate affinity. J. Antimicrob. Chemother. 15: 139-149, 1985.
6. Eliasson, I., Kamme, C., Vang, M. & Waley, S. G.: Characterization of cell-bound papain-soluble beta-lactamases in BRO-1 and BRO-2 producing strains of Moraxella (Branhamella) catarrhalis and Moraxella nonliquefaciens. Eur. J. Clin. Microbiol. Infect. Dis. 11: 313-321, 1992.
7. Farmer, T. & Reading, C.: β-lactamases of Branhamella catarrhalis and their inhibition by clavulanic acid. Antimicrob. Agents Chemother. 21: 506-508, 1982.
8. Fung C.-P., Yeo, S.-F. & Livermore, D. M.: Susceptibility of Moraxella catarrhalis isolates to β-lactam antibiotics in relation to β-lactamase pattern. J. Antimicrob. Chemother. 33: 215-222, 1994.
9. Luman, I., Wilson, R. W., Wallace, R. J. & Nash, D. R.: Disk diffusion susceptibility of Branhamella catarrhalis and relationship of β-lactam zone size to β-lactamase production. Antimicrob. Agents Chemother. 30: 774-776, 1986.
10. Malmvall, B.-E., Brorsson, J.-E. & Johnsson, J.: In vitro sensitivity to penicillin V and β-lactamase production of Branhamella catarrhalis. J. Antimicrob. Chemother. 3: 374, 1977.
11. Nagatake, T.: Clinical significance of respiratory infection caused by Branhamella catarrhalis with special reference to β-lactamase producing strains. Tohoku J. Exp. Med. 147: 1-13, 1985.
12. Nash, R. D., Wallace, R. J., Steingrube, V. A. & Shurin, P. A.: Isoelectric focusing of β-Iactamases from sputum and middle ear isolates of Branhamella catarrhalis recovered in the United States. Drugs 31 (Suppl. 3): 48-54, 1986.
13. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; Fourth Information Supplement. NCCLS Document M100-S4 )ISBN 1-56238-172-5). NCCLS, 771 E. Lancaster Avenue, Villanova, Pennsylvania: 19085, 1992.
14. Percival, A., Corkill, J. E., Rowlands, J. & Sykes, R. B.: Pathogenicity of and β-lactamase production by Branhamella (Neisseria) catarrhalis. Lancet ii: 1175, 1977.
15. Philippon, A., Riou, J. Y., Guibourdenche, M. & Sotolongo, F.: Detection, distribution and inhibition of Branhamella catarrhalis β-lactamases. Drugs 31 (Suppl. 3): 64-69, 1986.
16. Seto, W. H. & Yuen, K. Y.: The successful treatment of Branhamella catarrhalis bronchopulmonary infections in adults with amoxycillin. J. Antimicrob. Chemother. 26: 146-147, 1991.
17. Steingrube, V. A., Wallace, R. J. & Beaulieu, D.: A membrane-bound precursor β-lactamase in strains of Moraxella catarrhalis and Moraxella nonliquefaciens that produce periplasmic BRO-1 and BRO-2 β-lactamases. J. Antimicrob. Chemother. 31: 237-244, 1993.
18. Stohheringh, E. E., Davies, B. I. & Boven, C. P. A. v.: Branhamella catarrhalis: antibiotic sensitivities and β-lactamases. J. Antimicrob. Chemother. 13: 55-64, 1984.
19. Wallace, R. J., Steingrube, V. A., Nash, D. R., Hollis, D. G., Flanagan, C., Brown, B. A., Labidi, A. & Weaver, R. E.: BRO β-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal β-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M, lacunata. Antimicrob. Agents Chemother. 33: 1845-1854, 1989.